STAAR Surgical Company (STAA) Position Boosted by Geode Capital Management LLC

Geode Capital Management LLC raised its stake in shares of STAAR Surgical Company (NASDAQ:STAA) by 6.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 245,080 shares of the medical instruments supplier’s stock after buying an additional 14,420 shares during the period. Geode Capital Management LLC owned about 0.60% of STAAR Surgical worth $2,401,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of STAA. Teachers Advisors LLC raised its position in shares of STAAR Surgical by 3.7% in the fourth quarter. Teachers Advisors LLC now owns 71,882 shares of the medical instruments supplier’s stock valued at $780,000 after buying an additional 2,549 shares during the period. Candriam Luxembourg S.C.A. purchased a new stake in STAAR Surgical during the first quarter valued at approximately $441,000. Strs Ohio purchased a new stake in STAAR Surgical during the first quarter valued at approximately $251,000. Wells Fargo & Company MN increased its stake in STAAR Surgical by 30.6% in the first quarter. Wells Fargo & Company MN now owns 67,262 shares of the medical instruments supplier’s stock valued at $659,000 after buying an additional 15,769 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its stake in STAAR Surgical by 0.9% in the first quarter. Bank of New York Mellon Corp now owns 160,186 shares of the medical instruments supplier’s stock valued at $1,569,000 after buying an additional 1,392 shares in the last quarter. 75.79% of the stock is currently owned by hedge funds and other institutional investors.

STAAR Surgical Company (NASDAQ:STAA) traded up 0.84% during midday trading on Friday, hitting $11.95. The stock had a trading volume of 55,268 shares. The firm’s 50-day moving average price is $10.82 and its 200 day moving average price is $10.08. STAAR Surgical Company has a 12 month low of $7.46 and a 12 month high of $12.35. The company’s market cap is $491.24 million.

STAAR Surgical (NASDAQ:STAA) last announced its quarterly earnings data on Wednesday, August 2nd. The medical instruments supplier reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.05) by $0.04. STAAR Surgical had a negative return on equity of 8.69% and a negative net margin of 6.06%. The company had revenue of $21.90 million for the quarter, compared to analysts’ expectations of $22.15 million. During the same quarter in the prior year, the firm earned ($0.02) earnings per share. STAAR Surgical’s revenue was up 4.8% compared to the same quarter last year. On average, analysts expect that STAAR Surgical Company will post ($0.11) earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece was published by [[site]] and is the sole property of of [[site]]. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at [[permalink]].

Several research firms have recently commented on STAA. TheStreet upgraded STAAR Surgical from a “d+” rating to a “c” rating in a report on Tuesday, August 15th. BidaskClub upgraded STAAR Surgical from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. Benchmark Co. boosted their price objective on STAAR Surgical from $12.00 to $13.00 and gave the company a “buy” rating in a report on Monday, August 14th. Canaccord Genuity boosted their price objective on STAAR Surgical from $9.00 to $11.00 and gave the company a “hold” rating in a report on Thursday, August 3rd. Finally, Zacks Investment Research upgraded STAAR Surgical from a “sell” rating to a “hold” rating in a report on Wednesday, July 5th. Three research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $12.00.

About STAAR Surgical

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery.

Want to see what other hedge funds are holding STAA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STAAR Surgical Company (NASDAQ:STAA).